UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 12

of 'Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding'

12
TI
Clinically significant delayed postsphincterotomy bleeding: a twelve year single center experience.
AU
Ferreira LE, Fatima J, Baron TH
SO
Minerva Gastroenterol Dietol. 2007;53(3):215.
 
AIM: Bleeding following endoscopic biliary sphincterotomy (ES) is associated with morbidity. We sought to identify endoscopic findings and outcome of patients with delayed bleeding after ES.
METHODS: A retrospective study was carried out in a tertiary referral center. A gastrointestinal bleeding and endoscopy database was used to identify all patients with delayed post-ES bleeding from 1994 to 2006. Early endoscopic evaluation and endoscopic hemostasis was performed. Endoscopic findings, factors associated with bleeding severity, identification of stigmata of hemorrhage, and success of endoscopic treatment were identified.
RESULTS: There were 84 patients with delayed post-ES bleeding. Bleeding was classified as mild in 31 (36.9%), moderate in 29 (34.5%), and severe in 24 (28.6%). Thirteen of these 84 (15.5%) experienced bleeding at the time of initial ES. Endoscopic findings for evaluation of bleeding included active bleeding in 50 (59.5%) and stigmata of recent bleeding in 34 (40.5%) patients. Endoscopic treatment was employed in 74 (88%) patients. Monotherapy was used in 39.2% and combined therapy wasused in 60.8% patients. Recurrence of bleeding was significantly more common in the severe group (P<0.001). A multivariate analysis showed that coagulopathy was a predictive factor for severe post-ES bleeding.
CONCLUSION: Active bleeding or stigmata of hemorrhage occurs in the majority of patients with clinically significant delayed post-ES bleeding. Endoscopic therapy is useful in controlling bleeding in nearly all cases, though multimodal therapy and repeat endoscopic procedures may be required. Coagulopathy is a risk factor for severe bleeding; preventive measures in these patients may reduce morbidity.
AD
Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
PMID